Albemarle Corporation (NYSE:ALB) announced that it will increase global prices for generic active pharmaceutical ingredients by 8-12% depending on the specific product. The price increases will take effect October 15, 2011, or as contracts allow. Albemarle is committed to meeting the growing demand of our customers and regulatory agencies through continued investment in our business. This price increase will ensure that through a challenging economic environment, we are able to maintain the superior quality, regulatory status and services that our customers require and have come to expect from Albemarle.

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals in the United States and internationally. The company operates in three segments: Polymer Solutions, Catalysts, and Fine Chemistry.

Read more at: http://crwewallstreet.com/?p=21316